Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHLX
2101
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $1.3M | ﹤0.01% |
92,690
-169,828
| -65% | -$2.39M |
|
|
IBTX
2102
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.3M | ﹤0.01% |
19,204
-48,489
| -72% | -$3.38M |
|
2103
Milestone Pharmaceuticals
MIST
$141M
| $1.3M | ﹤0.01% |
211,710
-15,000
| -7% | -$92.2K |
|
|
SHAC
2104
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $1.3M | ﹤0.01% |
132,189
-22,471
| -15% | -$221K |
|
|
ZWRK
2105
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
| $1.3M | ﹤0.01% |
132,000
| – | – |
|
2106
South Plains Financial
SPFI
$841M
| $1.3M | ﹤0.01% |
53,787
-1,195
| -2% | -$29.2K |
|
2107
3D Systems Corp
DDD
$537M
| $1.3M | ﹤0.01% |
133,703
-58,869
| -31% | -$687K |
|
2108
Lincoln Electric
LECO
$14.6B
| $1.3M | ﹤0.01% |
10,521
+7,273
| +224% | +$958K |
|
|
SFIX
2109
Stitch Fix
SFIX
$560M
| $1.29M | ﹤0.01% |
261,487
+4,207
| +2% | +$35.2K |
|
2110
Brunswick
BC
$5.21B
| $1.28M | ﹤0.01% |
19,630
+14,208
| +262% | +$1.04M |
|
|
BPMC
2111
DELISTED
Blueprint Medicines
BPMC
| $1.28M | ﹤0.01% |
25,441
-2,427
| -9% | -$142K |
|
2112
Grab
GRAB
$15.5B
| $1.28M | ﹤0.01% |
507,552
-10,585
| -2% | -$30.4K |
|
|
ABCM
2113
DELISTED
Abcam PLC
ABCM
| $1.27M | ﹤0.01% |
87,963
+74,857
| +571% | +$1.16M |
|
|
JHG
2114
DELISTED
Janus Henderson
JHG
| $1.27M | ﹤0.01% |
54,111
-23,742
| -30% | -$682K |
|
2115
Avista
AVA
$3.25B
| $1.27M | ﹤0.01% |
29,199
-33,437
| -53% | -$1.44M |
|
|
SI
2116
DELISTED
Silvergate Capital Corporation
SI
| $1.27M | ﹤0.01% |
23,664
+23,657
| +337,957% | +$2.21M |
|
|
HTT
2117
High Templar Tech Ltd
HTT
$393M
| $1.26M | ﹤0.01% |
1,148,905
+1,048,349
| +1,043% | +$1.02M |
|
|
TUYA
2118
Tuya Inc
TUYA
$1.05B
| $1.26M | ﹤0.01% |
482,172
-22,000
| -4% | -$58.9K |
|
|
SMC
2119
Summit Midstream
SMC
$435M
| $1.26M | ﹤0.01% |
99,053
-69,773
| -41% | -$1.22M |
|
|
OZON
2120
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $1.26M | ﹤0.01% |
108,532
| – | – |
|
|
HI
2121
DELISTED
Hillenbrand
HI
| $1.26M | ﹤0.01% |
30,738
-33,727
| -52% | -$1.41M |
|
2122
Community Trust Bancorp
CTBI
$1.44B
| $1.26M | ﹤0.01% |
31,091
-9,372
| -23% | -$381K |
|
2123
Central Garden & Pet Co Class A
CENTA
$2.38B
| $1.25M | ﹤0.01% |
39,125
-23,623
| -38% | -$778K |
|
2124
Addus HomeCare
ADUS
$2.07B
| $1.25M | ﹤0.01% |
15,025
-7,635
| -34% | -$640K |
|
|
BENE
2125
DELISTED
Benessere Capital Acquisition Corp. Class A Common Stock
BENE
| $1.25M | ﹤0.01% |
120,816
-63,388
| -34% | -$653K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.